Literature DB >> 16810538

[Sepsis. Update on pathophysiology, diagnostics and therapy].

M Bauer1, F Brunkhorst, T Welte, H Gerlach, K Reinhart.   

Abstract

Sepsis results from the host response to infection. While a localized and controlled inflammatory reaction helps to control infection, a dysregulated response may lead to multiple organ failure and determines the course and prognosis of the septic patient. Despite intensive care, mortality remains as high as 54% for severe sepsis and septic shock. As the mechanisms are becoming better defined, interventions aiming to interfere with the host response have been undertaken, largely with disappointing results. Thus, many evidence-based recommendations suggest waiving of resource-consuming interventions. Nevertheless, several seminal studies have indicated that early and systematic supportive therapy according to pathophysiological principles, most notably early goal-directed therapy, low-dose hydrocortisone and activated protein C, can disrupt dysfunctional cascades and can favourably influence the course of the disease. In parallel, efforts to better define nationwide epidemiology and treatment habits for severe sepsis by the German competence network "SepNet" indicate that therapy of severe sepsis is generally in poor compliance with guidelines, while the personal perception of physicians in charge would suggest high rates of adherence. Thus, strategies of change management, such as implementation of sepsis bundles are warranted to achieve a better standard of care toward the aim of the "surviving sepsis campaign", i.e. a reduction of mortality by 25% within the next 5 years.

Entities:  

Mesh:

Year:  2006        PMID: 16810538     DOI: 10.1007/s00101-006-1034-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  62 in total

Review 1.  Pathogenesis of sepsis: new concepts and implications for future treatment.

Authors:  Pierre-Yves Bochud; Thierry Calandra
Journal:  BMJ       Date:  2003-02-01

Review 2.  Involvement of bacteria/endotoxin translocation in the development of multiple organ failure.

Authors:  S Bahrami; H Redl; Y M Yao; G Schlag
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

3.  Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients.

Authors:  Samir G Sakka; Konrad Reinhart; Andreas Meier-Hellmann
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

4.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

5.  The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.

Authors:  Christian Brun-Buisson; Françoise Roudot-Thoraval; Emmanuelle Girou; Catherine Grenier-Sennelier; Isabelle Durand-Zaleski
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

6.  Recovery of hepatocellular ATP and "pericentral apoptosis" after hemorrhage and resuscitation.

Authors:  Markus Paxian; Inge Bauer; Hauke Rensing; Hartmut Jaeschke; Angelika E M Mautes; Stefan A Kolb; Beate Wolf; Andre Stockhausen; Silke Jeblick; Michael Bauer
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

Review 7.  [Acute liver failure. Current aspects of diagnosis and therapy].

Authors:  M Bauer; M Paxian; A Kortgen
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

8.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996.

Authors:  M Crowe; P Ispahani; H Humphreys; T Kelley; R Winter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

View more
  5 in total

Review 1.  [Therapy of mediastinitis in patients with esophageal cancer].

Authors:  H Bartels; J R Siewert
Journal:  Chirurg       Date:  2008-01       Impact factor: 0.955

2.  [Neutropenia and sepsis].

Authors:  M Kochanek; B Böll; M Hallek; M von Bergwelt-Baildon
Journal:  Internist (Berl)       Date:  2013-09       Impact factor: 0.743

3.  Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host response.

Authors:  Nayla Jbeily; Iris Suckert; Falk A Gonnert; Benedikt Acht; Clemens L Bockmeyer; Sascha D Grossmann; Markus F Blaess; Anja Lueth; Hans-Peter Deigner; Michael Bauer; Ralf A Claus
Journal:  J Lipid Res       Date:  2012-12-10       Impact factor: 5.922

Review 4.  The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology.

Authors:  Thomas Schmoch; Florian Uhle; Benedikt H Siegler; Thomas Fleming; Jakob Morgenstern; Peter P Nawroth; Markus A Weigand; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

5.  Sepsis recognition in the emergency department - impact on quality of care and outcome?

Authors:  Marius Morr; Alexander Lukasz; Eva Rübig; Hermann Pavenstädt; Philipp Kümpers
Journal:  BMC Emerg Med       Date:  2017-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.